Author

R. Seri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. M. Chinnaiyan· 1 shared A. Parolia· 1 shared E. Young· 1 shared F. Su· 1 shared J. C.-Y. Tien· 1 shared J. George· 1 shared J. Luo· 1 shared M. Shahine· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. M. Chinnaiyan

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer

J. Luo, Z. Chen, Y. Qiao, J. C.-Y. Tien, E. Young, R. Mannan, S. Mahapatra, T. He, S. Eyunni, Y. Zhang, Y. Zheng, F. Su, X. Cao, R. Wang, Y. Cheng, , A. M. Chinnaiyan

This study shows that degrading p300/CBP in prostate cancer suppresses tumor growth more effectively than inhibiting their activity, highlighting their role in maintaining the active AR enhanceosome.

bioRxiv · Mar 29, 2024Cancer Biology